Under conditions of increased iron-bound Tf (Tf-saturation) or decreased Tf availability, such as conditions in cancer patients undergoing chemotherapy, levels of plasma non-transferrin-bound iron (NTBI) will increase significantly [17,18,19,20]. This evidence concerns the gene TF and cancer.